News & Updates

Show Multimedia Only

Let there be light: Repeated red-light therapy feasible for myopia control in kids

07 Dec 2021 by

Repeated, direct delivery of light on the retina can put brakes on axial elongation and myopic refraction progression in children with nearsightedness, according to a team of investigators from China.

Let there be light: Repeated red-light therapy feasible for myopia control in kids

07 Dec 2021

BRAF, MEK Inhibitors linked to ocular adverse effects

07 Dec 2021

Treatment with BRAF and MEK inhibitors for metastatic melanoma is associated with several ocular adverse effects (OAE), a study has shown.

BRAF, MEK Inhibitors linked to ocular adverse effects

07 Dec 2021

Are DOACs better than warfarin in patients undergoing bariatric surgery?

07 Dec 2021 by

A recent meta-analysis has shown a clinically higher pooled incidence of thromboembolism and mortality in patients on direct oral anticoagulants (DOACs) and that of bleeding in those on warfarin after bariatric surgery. However, the P values comparing the two groups are nonsignificant statistically.

Are DOACs better than warfarin in patients undergoing bariatric surgery?

07 Dec 2021

Preoperative RT at a nonsarcoma centre may increase wound complications after resection

07 Dec 2021

In patients with soft tissue sarcoma (STS), preoperative radiation therapy (RT) performed at an academic cancer centre, as opposed to those done at a community centre, results in fewer wound complications following resection, according to a study.

Preoperative RT at a nonsarcoma centre may increase wound complications after resection

07 Dec 2021

MRNA COVID-19 vaccines weaker in patients with autoimmune systemic diseases

07 Dec 2021 by

Patients with autoimmune systemic diseases (ASD) are less likely to produce an immune response following inoculation with mRNA vaccines against the coronavirus disease 2019 (COVID-19), according to a recent study.

MRNA COVID-19 vaccines weaker in patients with autoimmune systemic diseases

07 Dec 2021

Cholinesterase inhibitors show promise for treating gait disturbance in PD

07 Dec 2021

Treatment with cholinesterase inhibitors in patients with Parkinson’s disease (PD) leads to significant improvements in gait variability, with trending benefits for gait speed and fall prevention, according to the results of a meta-analysis.

Cholinesterase inhibitors show promise for treating gait disturbance in PD

07 Dec 2021

Novel antibody drug shows promise against pemphigus

07 Dec 2021

ALXN1830, a humanized IgG4 antibody that blocks the neonatal Fc receptor (FcRn), is safe for the treatment of pemphigus in adults, reports a recent pilot trial. Aside from a good tolerability profile, ALXN1830 also induces rapid improvements in disease severity.

Novel antibody drug shows promise against pemphigus

07 Dec 2021

Older women with cervical cancer face bleak outcomes

07 Dec 2021

Cervical cancer stands out as a major concern for older women who are frequently undertreated and are at higher risk of death, a study reports.

Older women with cervical cancer face bleak outcomes

07 Dec 2021

Computer-assisted rapid movement training beneficial for fall prevention after stroke

07 Dec 2021 by

A randomized clinical trial conducted by researchers from the Chinese University of Hong Kong (CUHK) and clinicians at Shatin Hospital and Prince of Wales Hospital in Hong Kong finds computer-assisted rapid movement training (RMT) to be as effective as conventional balance training (CBT) at improving chronic stroke survivors’ overall balance, motor function and balance recovery, indicating potential for home-based telerehabilitation.

Computer-assisted rapid movement training beneficial for fall prevention after stroke

07 Dec 2021

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

07 Dec 2021 by

An observational single-institution cohort study provides evidence that levetiracetam use throughout the duration of standard chemotherapy is associated with longer median overall survival (OS) in patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma.

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

07 Dec 2021

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Let there be light: Repeated red-light therapy feasible for myopia control in kids

Let there be light: Repeated red-light therapy feasible for myopia control in kids

BRAF, MEK Inhibitors linked to ocular adverse effects

BRAF, MEK Inhibitors linked to ocular adverse effects

Are DOACs better than warfarin in patients undergoing bariatric surgery?

Are DOACs better than warfarin in patients undergoing bariatric surgery?

Preoperative RT at a nonsarcoma centre may increase wound complications after resection

Preoperative RT at a nonsarcoma centre may increase wound complications after resection

MRNA COVID-19 vaccines weaker in patients with autoimmune systemic diseases

MRNA COVID-19 vaccines weaker in patients with autoimmune systemic diseases

Cholinesterase inhibitors show promise for treating gait disturbance in PD

Cholinesterase inhibitors show promise for treating gait disturbance in PD

Novel antibody drug shows promise against pemphigus

Novel antibody drug shows promise against pemphigus

Older women with cervical cancer face bleak outcomes

Older women with cervical cancer face bleak outcomes

Computer-assisted rapid movement training beneficial for fall prevention after stroke

Computer-assisted rapid movement training beneficial for fall prevention after stroke

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

Levetiracetam associated with longer OS in IDH wild-type glioblastoma